#tacrolimus

New Study Confirms Cheap, Decades-Old Drug Still Has Zero Luxury Branding Potential

Major Pharmaceutical Companies Express Bewilderment at a Viable Treatment Option that Doesn't Require a $12,000 Annual Markup.